Hepatic steatosis is one of the reasons for ALT abnormality during NA treatment, but it should be noted that the patients who developed HCC showed a significantly lower frequency of hepatic steatosis (Table 1), consistent with previous reports [24, 25]. Here, GPT is linked to fatty liver disease.